Artelo Biosciences
ARTL
NASDAQ
IPO2015
about ARTL
Artelo Biosciences is a biopharmaceutical company focused on precision medicine, specializing in the development of innovative therapies for inflammation and immune-mediated diseases using cutting-edge technologies to address chronic inflammatory conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.40 | $4.66 | $4.20 | $5.75M | 618.01K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.00 | n/a | n/a | 0% | 0% | 0% |